W81XWH2211066
Project Grant
Overview
Grant Description
Evaluation of an innovative therapeutic to prevent and/or delay the progression of ALI/ARDS in a non-human primate model.
Awardee
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Mount Pleasant,
South Carolina
294648380
United States
Geographic Scope
Single Zip Code
Related Opportunity
0011755104
Xequel Bio was awarded
Project Grant W81XWH2211066
worth $1,680,000
from Medical Command in September 2022 with work to be completed primarily in Mount Pleasant South Carolina United States.
The grant
has a duration of 3 years and
was awarded through assistance program 12.420 Military Medical Research and Development.
Status
(Ongoing)
Last Modified 9/21/22
Period of Performance
9/30/22
Start Date
9/29/25
End Date
Funding Split
$1.7M
Federal Obligation
$0.0
Non-Federal Obligation
$1.7M
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
W81XWH2211066
SAI Number
None
Award ID URI
None
Awardee Classifications
Small Business
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
W91ZSQ W03J HQ CO USA MED DEV MAT CM
Awardee UEI
T4JKC8B27PJ7
Awardee CAGE
4GLF5
Performance District
01
Senators
Lindsey Graham
Tim Scott
Tim Scott
Representative
Nancy Mace
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Defense Health Program, Defense (097-0130) | Department of Defense-Military | Grants, subsidies, and contributions (41.0) | $1,680,000 | 100% |
Modified: 9/21/22